Innocan Pharma Announces Presentation of Narrative Review on Long-Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference
, June 20, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, proudly announces that the recently published narrative review titled "Considering Long-Acting Synthetic Cannabidiol for Chronic Pain: A Narrative Review" (DOI: https://doi.org/10.7759/cureus.81577) has been officially accepted for presentation at PAINWEEK 2025, the national conference on pain management, taking place this September in Las Vegas, Nevada.
PAINWEEK is a prestigious event that brings together leading clinicians, researchers, and educators in the field of pain medicine, offering a unique platform to showcase innovative research and best practices. The narrative review, selected through a competitive peer-review process, provides important insights into the potential of synthetic cannabidiol (CBD), administered through extended-release formulations, as a well-tolerated, non-opioid analgesic alternative.
Innocan is developing LPT-CBD, an innovative injectable liposomal drug product designed for the sustained release of synthetic CBD. Supported by multiple animal studies, LPT-CBD has demonstrated steady plasma CBD levels for up to four weeks, prolonged pain relief, and excellent tolerability—offering a promising alternative to current opioid medications and addressing the urgent need to reduce opioid dependency.
LPT-CBD will be showcased at the PAINWEEK conference to thousands of healthcare professionals and potential pharmaceutical partners, positioning it at the forefront of groundbreaking non-opioid chronic pain management solutions.
"We are honored to be included among the esteemed voices presenting at PAINWEEK this year," said Iris Bincovich, Chief Executive Officer of Innocan."This recognition underscores our commitment to advancing evidence-based pain care and contributing meaningful research to the field."
About Innocan:
Innocan is an innovator in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, Innocan developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of synthetic CBD for non-opioid pain management. In the wellness sector, Innocan develops and markets a wide portfolio of high-performance self-care and beauty products to promote a healthier lifestyle. Under this segment Innocan carries on business through its 60% owned subsidiary, BI Sky Global Ltd., which focuses on advanced, targeted online sales.
Contact Information:
For Innocan Pharma Corporation:
Iris Bincovich, CEO
+1 5162104025
+972-54-3012842
+442037699377
[email protected]
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Caution Regarding Forward-Looking Information
Certain information set forth in this news release, including, without limitation, the Company's plans for human trials of its LPT-CBD platform, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan's control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of production and distribution arrangements.
Forward-looking information is subject to various risks and uncertainties that could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: global and local (national) economic, political, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and potential disruption of relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import/export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner). The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release. A comprehensive discussion of other risks that impact Innocan can be found in Innocan's public reports and filings which are available under Innocan's profile at www.sedarplus.ca.
Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward-looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
3 hours ago
- Cision Canada
enCore Energy Announces Filing of Early Warning Report
DALLAS, June 20, 2025 /CNW/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the"Company" or "enCore"), America's Clean Energy Company ™, announces that it has disposed of 170,000,000 common shares in the capital of Anfield Energy Inc. (" Anfield") (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) in a private agreement at a price of $0.115 per share for aggregate proceeds of $19,550,000 (Canadian dollars). Immediately following the disposition, enCore holds or controls no common shares of Anfield. The disposition represents a 14.73% decrease in enCore's ownership or control over the outstanding common shares of Anfield on an undiluted basis. enCore does not currently hold or control any securities of Anfield. Since enCore's last early warning report dated January 15, 2024, enCore's holdings have decreased by an approximate 16.02% of the outstanding common shares of Anfield on an undiluted basis. enCore disposed of the shares of Anfield in a private transaction. enCore may, depending on market and other conditions, increase beneficial ownership of the Company's securities, whether in the open market, by privately negotiated agreements or otherwise, subject to a number of factors, including general market conditions and other available investment and business opportunities. The disclosure respecting enCore's shareholdings contained in this news release is made pursuant to National Instrument 62-103 and a report respecting the above disposition will be filed with the applicable securities commissions and will be available for viewing at A copy of the report may also be obtained by contacting Robert Willette, Acting Chief Executive Officer, or at [email protected]. About enCore Energy Corp. enCore Energy Corp., America's Clean Energy Company ™, is committed to providing clean, reliable, and affordable fuel for nuclear energy as the only United States uranium company with multiple central processing plants in operation. enCore operates the 100% owned and operated Rosita CPP in South Texas and the 70/30 joint venture Alta Mesa CPP with Boss Energy Ltd., with enCore operating as the project manager. The enCore team is led by industry experts with extensive knowledge and experience in all aspects of ISR uranium operations and the nuclear fuel cycle. enCore solely utilizes ISR for uranium extraction, a well-known and proven technology co-developed by the leaders at enCore Energy. Following upon enCore's demonstrated success in South Texas, future projects in enCore's planned project pipeline include the Dewey-Burdock project in South Dakota and the Gas Hills project in Wyoming. The Company holds other assets including non-core assets and proprietary databases. enCore is committed to working with local communities and indigenous governments to create positive impact from corporate developments.
Cision Canada
3 hours ago
- Cision Canada
Statement from Dennis Darby, President & CEO, Canadian Manufacturers & Exporters regarding passage of C-5, the One Canadian Economy Act, in the House of Commons
OTTAWA, ON, June 20, 2025 /CNW/ - Canadian Manufacturers & Exporters (CME) welcomes today's passage of Bill C-5, the One Canadian Economy Act, through the House of Commons. This legislation marks a meaningful first step toward fixing Canada's fragmented and inefficient approach to infrastructure approvals - one that has held back investment, delayed major projects, and weakened our economic competitiveness. From highways and ports to pipelines and clean energy infrastructure, Canada needs to get major projects moving - faster. Bill C-5 can help pave the way for clearer oversight, reduced duplication and greater government accountability, all of which are vital building the infrastructure our economy depends on. But this is only the beginning. The passage of Bill C-5 must not be the end of the conversation - it must be the starting point for a broader transformation. The federal government must now turn its attention to a much harder task: tackling the underlying web of outdated legislation, regulatory inefficiencies, and policy contradictions that have made a bill like this necessary in the first place. Until those deeper barriers are addressed, Canada will continue to struggle to attract private sector investment in the kinds of projects - big and small, urban and rural - that create jobs, grow communities, and position our economy for long-term success. Manufacturers are looking for outcomes, not just intentions. We look forward to the Bill passing in the Senate so that we can build on this momentum and do the hard work needed to truly unlock Canada's potential. About Canadian Manufacturers & Exporters (CME) From the first industrial boom in Canada, CME has advocated for and represented member interests. 150 years strong, CME has earned an extensive and effective track record of working for thousands of leading companies nationwide. More than 85 per cent of CME's members are SMEs and collectively account for an estimated 82 per cent of total manufacturing production and 90 per cent of Canada's exports.
Cision Canada
4 hours ago
- Cision Canada
House of Commons passes One Canadian Economy Act Français
OTTAWA, ON, June 20, 2025 /CNW/ - Canada's new government has a mandate to build big, build bold, and build now. Today, the Prime Minister, Mark Carney, welcomed the passing in the House of Commons of Bill C-5, One Canadian Economy Act. The legislation will build one strong Canadian economy by: Removing federal barriers to internal trade and labour mobility, helping goods, services, workers, and businesses move freely across provinces and territories. Expediting nation-building projects that will connect and transform our country and unleash economic growth while ensuring environmental protections and Indigenous rights are upheld. Working with Indigenous Peoples through consultation and engagement to build shared prosperity. Taken together, these measures will create and connect Canadians to good-paying careers and more prosperity. The Prime Minister shared an update on this work with the premiers of the provinces and territories during their meeting earlier today. The leaders agreed to stay in close contact as they reinforce Canada's strength at home. Indigenous partnership is a critical component of this legislation, and fulsome consultation will be pivotal to the success of future projects. The Government of Canada is committed to respecting the rights of Indigenous Peoples recognized and affirmed by section 35 of the Constitution Act, 1982 and the rights set out in the United Nations Declaration on the Rights of Indigenous Peoples. To this end, Prime Minister Carney will be meeting with First Nations, Inuit, and Métis over the coming weeks. Bill C-5 now moves to the Senate for consideration and brings us one step closer to removing federal barriers to free trade by Canada Day. Quotes "Today's passing of Bill C-5, One Canadian Economy Act, will remove trade barriers, expedite nation-building projects, and unleash economic growth, with Indigenous partnership at the centre of this growth. It's time to build big, build bold, and build now. As Canadians, we can give ourselves more than any foreign nation can ever take away." — The Rt. Hon. Mark Carney, Prime Minister of Canada "The adoption of Bill C-5 by the House of Commons is a crucial step in building one Canadian economy and getting big projects built faster. Thank you to colleagues who supported this legislation – you are helping build a stronger Canada." — The Hon. Dominic LeBlanc, President of the King's Privy Council for Canada and Minister responsible for Canada-U.S. Trade, Intergovernmental Affairs and One Canadian Economy "This legislation is about building a stronger, more united Canada. Let's build trust, tear down internal trade barriers, and create one single economy – from coast to coast to coast. Together, we're building a stronger Canada, for everyone." — The Hon. Chrystia Freeland, Minister of Transport and Internal Trade "I am pleased to see the One Canadian Economy Act achieve this milestone. This Act means we are no longer asking 'Why build?', but instead 'How do we get it done?'. We are removing barriers, leveraging Canada's resources and talented workers, centring Indigenous consultation and equity, and continuing to fight climate change – all to get building and to become an energy superpower. In the new economy we are building, Canada will be defined by delivery, not delay." — The Hon. Tim Hodgson, Minister of Energy and Natural Resources "Indigenous Peoples' voices are at the table where discussions are happening, and decisions are made. This government understands that Indigenous Peoples have the right to determine their future. As the first Indigenous Minister of Indigenous Services, I understand the importance of relationship moving forward – and I am pleased to see the Prime Minister has determined this as a priority and a critical part of the work ahead." — The Hon. Mandy Gull-Masty, Minister of Indigenous Services
